ASBP

Aspire Biopharma Holdings, Inc. (ASBP) SWOT Analysis Analysis (2026)

Invetso Score: 7.4/10 — Strong · Last Updated: 2026-09-01

Strengths

Strong liquidity with a current ratio of 7.99 and cash ratio of 7.22, supported by cash per share of 11.72.

Balance sheet remains debt-light, with debt-to-assets and debt-to-equity both at 0 and net current asset value of 11.68M.

Shares screen below book value at 0.79x P/B and below net-net value, suggesting asset-backed downside support.

Weaknesses

Profitability remains deeply negative, with net profit margin at -113.14% and EBIT margin at -64.66%.

Operating efficiency is very weak, with asset turnover at 0.007 and operating cash flow per share at -6.92.

Cash generation is poor despite reported liquidity, as operating cash flow is -4.26 and free cash flow per share is -6.92.

Opportunities

The stock trades at a low price-to-book multiple of 0.79x, leaving room for rerating if execution improves.

Net-net value of 10.14 per share and cash per share of 11.72 provide a tangible asset base that could support value-oriented upside.

If management can convert the current gross margin of 18.35% into sustainable operating leverage, earnings power could improve materially.

Threats

Sustained losses and negative operating cash flow increase the risk of dilution or further balance-sheet stress.

Interest coverage is negative at -0.76x, indicating limited ability to service financing costs from current operations.

Extremely weak turnover metrics, including inventory turnover of 0.28 and cash conversion cycle of -3129 days, point to severe working-capital distortion and execution risk.

Overall Score

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Aspire Biopharma Holdings, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →